CII
Capital International Inc Portfolio holdings
AUM
$10.3B
1-Year Return
33.09%
This Quarter Return
-6.15%
1 Year Return
+33.09%
3 Year Return
+130.02%
5 Year Return
+217.83%
10 Year Return
+680.45%
AUM
$8.92B
AUM Growth
-$1.83B
(-17%)
Cap. Flow
-$706M
Cap. Flow
% of AUM
-7.91%
Top 10 Holdings %
Top 10 Hldgs %
23.23%
Holding
318
New
16
Increased
69
Reduced
201
Closed
23
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$53.9M |
| 2 |
Norwegian Cruise Line
NCLH
|
$48.9M |
| 3 |
Wolfspeed
WOLF
|
$42.3M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$40.3M |
| 5 |
Pfizer
PFE
|
$39.6M |
Top Sells
| 1 |
Tesla
TSLA
|
$88.7M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$68.1M |
| 3 |
Amazon
AMZN
|
$51.2M |
| 4 |
L3Harris
LHX
|
$49.8M |
| 5 |
Church & Dwight Co
CHD
|
$44.7M |
Sector Composition
| 1 | Technology | 23.3% |
| 2 | Healthcare | 14.2% |
| 3 | Consumer Discretionary | 14.07% |
| 4 | Financials | 13.11% |
| 5 | Industrials | 10.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
American Tower
AMT
$89.6B
| $3.3M | 0.04% |
13,143
-3,865
| -23% | -$971K |
|
202
VF Corp
VFC
$5.94B
| $3.26M | 0.04% |
57,335
+375
| +0.7% | +$21.3K |
|
|
XM
203
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
| $3.22M | 0.04% |
112,670
+46,508
| +70% | +$1.33M |
|
204
Zimmer Biomet
ZBH
$20.7B
| $3.2M | 0.04% |
24,986
+7,677
| +44% | +$982K |
|
205
Alnylam Pharmaceuticals
ALNY
$59.8B
| $3.17M | 0.04% |
+19,390
| New | +$3.17M |
|
206
NVR
NVR
$23.4B
| $3.15M | 0.04% |
706
-9
| -1% | -$40.2K |
|
207
Rockwell Automation
ROK
$38.6B
| $3.14M | 0.04% |
11,229
-4,690
| -29% | -$1.31M |
|
208
Concentrix
CNXC
$3.31B
| $3.06M | 0.03% |
18,373
-3,411
| -16% | -$568K |
|
209
Ultragenyx Pharmaceutical
RARE
$3.05B
| $3.01M | 0.03% |
41,492
-58,206
| -58% | -$4.23M |
|
210
Fabrinet
FN
$13.1B
| $3M | 0.03% |
28,499
| – | – |
|
211
Guardant Health
GH
$7.43B
| $2.99M | 0.03% |
45,150
+16,132
| +56% | +$1.07M |
|
|
SMAR
212
DELISTED
Smartsheet Inc.
SMAR
| $2.9M | 0.03% |
52,841
-23,888
| -31% | -$1.31M |
|
213
Morgan Stanley
MS
$236B
| $2.85M | 0.03% |
32,623
+3,679
| +13% | +$322K |
|
214
CSX Corp
CSX
$60.4B
| $2.81M | 0.03% |
74,906
-90,377
| -55% | -$3.38M |
|
|
BHVN
215
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $2.77M | 0.03% |
23,350
-7,986
| -25% | -$947K |
|
216
FTI Consulting
FCN
$5.32B
| $2.74M | 0.03% |
17,456
-3,743
| -18% | -$588K |
|
217
Tandem Diabetes Care
TNDM
$848M
| $2.74M | 0.03% |
23,588
-24,273
| -51% | -$2.82M |
|
218
Toll Brothers
TOL
$14.2B
| $2.74M | 0.03% |
58,208
-271
| -0.5% | -$12.7K |
|
219
Regal Rexnord
RRX
$9.5B
| $2.73M | 0.03% |
+18,342
| New | +$2.73M |
|
220
Incyte
INCY
$16.8B
| $2.7M | 0.03% |
33,961
-79,025
| -70% | -$6.28M |
|
221
Monster Beverage
MNST
$61.2B
| $2.65M | 0.03% |
66,262
-7,916
| -11% | -$316K |
|
|
SBNY
222
DELISTED
Signature Bank
SBNY
| $2.58M | 0.03% |
8,804
+6,404
| +267% | +$1.88M |
|
223
Grifois
GRFS
$6.87B
| $2.55M | 0.03% |
218,419
-89,420
| -29% | -$1.04M |
|
224
Silicon Laboratories
SLAB
$4.41B
| $2.55M | 0.03% |
16,986
-145
| -0.8% | -$21.8K |
|
225
Nutrien
NTR
$27.7B
| $2.45M | 0.03% |
+23,734
| New | +$2.45M |
|